Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004074

Locations


United States, Ohio
	Arthur G. James Cancer Hospital - Ohio State University
	Columbus, Ohio, United States, 43210-1240

Sponsors and Collaborators

Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

National Cancer Institute (NCI)

Investigators


Study Chair:	William E. Carson, MD	Arthur G. James Cancer Hospital & Richard J. Solove Research Institute